Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Arellano

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 31, 2022
Bone Microenvironment-Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in MiceDanna L Arellano, Patricia Juárez, Andrea Verdugo-Meza, et al.
Journal of Community Health Nursing|November 9, 2023
Assessing Dietary Salt Intake and Pilot-Testing a Home-Based Intervention to Lower Salt Intake Among Filipino College StudentsAngelo Joaquin M Armas, Jade Alexie E Aranda, Hyacintha S Arcos, et al.
Oncogene|June 9, 2016
Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisininS Elf, R Lin, S Xia, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2016
Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?Zachariah DeFilipp, Amelia A Langston, Zhengjia Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 MutationsDaniel A Pollyea, Courtney D DiNardo, Martha L Arellano, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|September 1, 2021
Survey of Nurses' Experiences Applying The Joint Commission's Medication Management Titration StandardsJudy E Davidson, Neal Doran, Amber Petty, et al.
British Journal of Haematology|July 5, 2012
Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phaseDisni Muringampurath-John, David L Jaye, Christopher R Flowers, et al.
Blood Cancer Journal|March 29, 2025
Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemiaVinod Pullarkat, Keith W Pratz, Hartmut Döhner, et al.
Blood Advances|April 19, 2024
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndromeCourtney D DiNardo, Gail J Roboz, Justin M Watts, et al.
Cancer Cell|February 12, 2015
Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growthLingtao Jin, Dan Li, Gina N Alesi, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 31, 2022
Bone Microenvironment-Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in MiceDanna L Arellano, Patricia Juárez, Andrea Verdugo-Meza, et al.
Journal of Community Health Nursing|November 9, 2023
Assessing Dietary Salt Intake and Pilot-Testing a Home-Based Intervention to Lower Salt Intake Among Filipino College StudentsAngelo Joaquin M Armas, Jade Alexie E Aranda, Hyacintha S Arcos, et al.
Oncogene|June 9, 2016
Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisininS Elf, R Lin, S Xia, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2016
Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?Zachariah DeFilipp, Amelia A Langston, Zhengjia Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 MutationsDaniel A Pollyea, Courtney D DiNardo, Martha L Arellano, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|September 1, 2021
Survey of Nurses' Experiences Applying The Joint Commission's Medication Management Titration StandardsJudy E Davidson, Neal Doran, Amber Petty, et al.
British Journal of Haematology|July 5, 2012
Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phaseDisni Muringampurath-John, David L Jaye, Christopher R Flowers, et al.
Blood Cancer Journal|March 29, 2025
Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemiaVinod Pullarkat, Keith W Pratz, Hartmut Döhner, et al.
Blood Advances|April 19, 2024
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndromeCourtney D DiNardo, Gail J Roboz, Justin M Watts, et al.
Cancer Cell|February 12, 2015
Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growthLingtao Jin, Dan Li, Gina N Alesi, et al.
Pageof 12